81 results
S-8
EX-99.3
NGNE
Neurogene Inc
20 Feb 24
Registration of securities for employees
4:16pm
.
Participation
An Eligible Employee may participate in the Plan by (i) submitting to the Company’s human resources department (or its delegate … by (a) submitting to the Company’s human resources department (or its delegate) a written notice of withdrawal in the form determined
8-K
EX-10.6
NGNE
Neurogene Inc
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
that is not a stock transfer agent of national reputation or the corporate trust department of a commercial bank.
(f) The Rights Agent … , which shall not constitute notice, to:
Equiniti Trust Company, LLC
48 Wall Street, 22nd Floor
New York, NY 10005
Attention: Legal Department
Email
8-K
EX-10.22
NGNE
Neurogene Inc
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
.
Participation
An Eligible Employee may participate in the Plan by (i) submitting to the Company’s human resources department (or its delegate … time by (a) submitting to the Company’s human resources department (or its delegate) a written notice of withdrawal in the form determined
425
NGNE
Neurogene Inc
4 Dec 23
Business combination disclosure
5:14pm
agent of national reputation or the corporate trust department of a commercial bank.
(f) The Rights Agent will reasonably cooperate with the Company … notice, to:
Equiniti Trust Company, LLC
48 Wall Street, 22nd Floor
New York, NY 10005
Attention: Legal Department
Email: LegalTeamUS
8-K
EX-10.1
lpql1 74zzq6
4 Dec 23
Other Events
5:10pm
S-4/A
4bmnt 48hfbdmd
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.36
kz2aqn4z54fg4
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.31
v95wuhjh e8yrt0h
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4/A
EX-10.35
p2vhbab4ysjv0cd1
28 Sep 23
Registration of securities issued in business combination transactions (amended)
4:28pm
S-4
br74qtkv
18 Aug 23
Registration of securities issued in business combination transactions
6:19pm
425
5v5t428kmaivwyb0
18 Jul 23
Business combination disclosure
8:37am
8-K
EX-10.5
2so0rg yoofimmu
18 Jul 23
Neurogene and Neoleukin Announce Definitive Merger Agreement
8:34am
8-K
EX-2.1
r2fc7ziggbu2et9 9vep
18 Jul 23
Neurogene and Neoleukin Announce Definitive Merger Agreement
8:34am
8-K
EX-10.1
1pppi6w d7a
18 Jul 23
Neurogene and Neoleukin Announce Definitive Merger Agreement
8:34am